Diversity of the cultivable human gut microbiome involved in gluten metabolism: Isolation of microorganisms with potential interest for coeliac disease

FEMS Microbiology Ecology

Volumn 88, Issue 2, 2014, Pages 309-319

  Caminero, Alberto ^a   Herrán, Alexandra R ^a   Nistal, Esther ^a   Pérez Andrés, Jenifer ^a   Vaquero, Luis ^b   Vivas, Santiago ^a,b   Ruiz de Morales, José María G ^a,b   Albillos, Silvia M ^c   Casqueiro, Javier ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b HOSPITAL DE LEÓN   (Spain)

^c Institute of Biotechnology INBIOTEC Parque Científico de León   (Spain)

Author keywords

33 mer hydrolysis; Gluten metabolism; Gluten proteolysis; Gut microbiota; Proteolytic bacteria

Indexed keywords

ACTINOBACTERIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIUM; FIRMICUTES; LACTOBACILLUS; STAPHYLOCOCCUS; STREPTOCOCCUS;

GLUTEN; PEPTIDE HYDROLASE;

33-MER HYDROLYSIS; ACTINOBACTERIA; ADULT; ARTICLE; BACTERIUM; BIODIVERSITY; CELIAC DISEASE; CLASSIFICATION; CULTURE MEDIUM; ENZYMOLOGY; FECES; FEMALE; GLUTEN METABOLISM; GLUTEN PROTEOLYSIS; HUMAN; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PROTEOLYTIC BACTERIA; YOUNG ADULT;

33-MER HYDROLYSIS; GLUTEN METABOLISM; GLUTEN PROTEOLYSIS; GUT MICROBIOTA; PROTEOLYTIC BACTERIA;

ACTINOBACTERIA; ADULT; BACTERIA; BIODIVERSITY; CELIAC DISEASE; CULTURE MEDIA; FECES; FEMALE; GLUTENS; HUMANS; INTESTINES; MALE; MICROBIOTA; MIDDLE AGED; PEPTIDE HYDROLASES; YOUNG ADULT;

EID: 84899950452     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1111/1574-6941.12295     Document Type: Article

References (30)

1. Bernardo D, Garrote JA, Nadal I, León AJ, Calvo AJ, Fernández-Salazar L, Blanco-Quirós A, Sanz Y & Arranz E (2009) Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa. Gut 58: 886-887.
2. Bethune MT & Khosla C (2012) Oral enzyme therapy for celiac sprue. Methods Enzymol 502: 241-271.
3. Caminero A, Nistal E, Arias L et al. (2012) A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. Eur J Nutr 51: 293-299.
4. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M & Sanz Y (2009) Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 62: 264-269.
5. Comino I, Real A, Vivas S, Síglez M, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrero A, Cebolla A & Sousa C (2012) Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 95: 670-677.
6. Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y & Tomé D (2013) Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res 1: 95-107.
7. De Palma G, Nadal I, Collado MC & Sanz Y (2009) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 102: 1154-1160.
8. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, Calabuig M & Sanz Y (2010) Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 10: 63.
9. Di Cagno R, De Angelis M, Lavermicocca P, De Vincenci M, Giovannini C, Faccia M & Gobbetti M (2002) Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 68: 623-633.
10. Fasano A (2009) Surprises from celiac disease. Sci Am 301: 54-61.
11. Fernandez-Feo M, Wei G, Blumenkranz G, Dewhirst FE, Schuppan D, Oppenheim FG & Helmerhosrt EJ (2013) The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect 19: E386-E394.
12. Gerez CL, Dallagnol A, Rollán G & Font de Valdez GA (2012) A combination of two lactic acid bacteria improves the hydrolysis of gliadin during wheat dough fermentation. Food Microbiol 32: 427-430.
13. Helmerhorst EJ, Zamakhchari M, Schuppan D & Oppenheim FG (2010) Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. PLoS One 5: e13264.
14. Kagnoff M (2007) Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 117: 41-49.
15. Kunji ER, Mierau I, Hagting A, Poolman B & Konings WN (1996) The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek 70: 187-221.
16. Laparra JM & Sanz Y (2010) Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 109: 801-807.
17. Laparra JM, Olivares M, Gallina O & Sanz Y (2012) Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7: e30744.
18. Ludvigsson JF, Leffler DA, Bai JC et al. (2012) The Oslo definitions for coeliac disease and related terms. Gut 62: 43-52.
19. Nistal E, Caminero A, Vivas S, Ruiz de Morales JM, Sáenz de Miera LE, Rodríguez-Aparicio LB & Casqueiro J (2012) Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 94: 1724-1729.
20. Pessione E (2012) Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol 2: 86.
21. Pruteanu M, Hyland NP, Clarke DJ, Kiely B & Shanahan F (2011) Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis 17: 1189-1200.
22. Sánchez E, Laparra JM & Sanz Y (2012) Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol 78: 6507-6515.
23. Sanz Y, De Palma G & Laparra M (2011) Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 30: 207-218.
24. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM & Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
25. Snydman DR (2008) The safety of probiotics. Clin Infect Dis 46(suppl 2): S104-S111; discussion S44-51
26. Steck N, Mueller K, Schemann M & Haller D (2012) Bacterial proteases in IBD and IBS. Gut 61: 1610-1618.
27. Tamura K, Dudley J, Nei M & Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
28. Thompson JD, Higgins DG & Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
29. Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO & van Sinderen D (2014) Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71: 183-203.
30. Zamakhchari M, Wei G, Dewhirst F, Lee J, Schuppan D, Oppenheim FG & Helmerhorst EJ (2011) Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. PLoS One 6: e24455.